Checking your sign-in status…

Private workspace

Finance

Research, portfolio tools, and market analysis in one place.

Finance home
Back to US Equities

US Equities · Finance research note

EFX — Equifax

Research and analysis only
View analysis Browse US Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 17.45%
Profit Margins 11.12%
Return on Equity 14.37%
Return on Assets 6.27%
Free Float 0.12B
Dividend Yield 1.47%
Short Int % Utilisation 5.73%

2.2 Growth

Metric Value
Revenue Growth 14.3%
Free Cash Flow 1.02B
EBITDA 12.98 (Ratio)
Enterprise Value 25.04B
EV/Revenue 3.99
EV/EBITDA 12.98

Revenue growth of 14.3% indicates steady, moderate expansion.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* -20.67%
Risk / Std Dev (Ann.)* 38.52%
1-Year Price Return* -26.22%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $180.85
52-Week Range $150.75 – $271.84
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in US$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont component Calculation FY2025 FY2024
Revenue Reported revenue $6.07B $5.68B
Net income Reported net income $660.30M $604.10M
Total assets Year-end reported balance $11.86B $11.76B
Shareholders’ equity Year-end reported balance $4.60B $4.80B
Net margin Net income ÷ revenue 10.87% 10.63%
Asset turnover Revenue ÷ total assets 0.5120x 0.4831x
Equity multiplier Total assets ÷ shareholders’ equity 2.5768x 2.4515x
ROE Net margin × asset turnover × equity multiplier 14.34% 12.59%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $6.07B
Prior annual revenue $5.68B
EBIT $1.11B
Tax rate 25.80%
NOPAT = EBIT × (1 − tax rate) $821.54M
Forecast start-growth basis 6.92%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $821.54M
Add: depreciation & amortisation $726.90M
Less: capital expenditure -$481.40M
Less/(add): working-capital cash-flow movement $117.10M
Current unlevered FCFF $1.18B

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 6.92% $878.43M $777.24M -$514.74M $125.21M $1.27B $1.21B
2 5.82% $929.54M $822.46M -$614.13M $132.49M $1.27B $1.10B
3 4.71% $973.35M $861.22M -$715.78M $138.74M $1.26B $987.32M
4 3.61% $1.01B $892.27M -$816.94M $143.74M $1.23B $874.88M
5 2.50% $1.03B $914.58M -$914.58M $147.33M $1.18B $764.09M

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 1.30
Cost of equity 11.84%
Pre-tax cost of debt 4.20%
WACC 10.16%
WACC validation within standard range

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $15.80B
Implied terminal EV / EBITDA 6.85x
Terminal value as % of enterprise value 66.39%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF $4.93B
Present value of terminal value $9.74B
Indicated enterprise value $14.67B
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $14.67B
Less: gross interest-bearing debt $5.09B
Add: cash and equivalents $180.80M
Add: affiliate investments $0.00
Less: minority interests $133.90M
Indicated common equity value $9.63B

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 124,100,000.00
Share-count basis reported diluted weighted-average shares
Current market price $181.68
DCF indicative value per share $77.57
Indicative value vs. market price -57.30%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range pass
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration within review band
Implied price differs from spot by more than 30% review required

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 4/4 evidenced checks
Lynch-inspired balance-and-growth checks 4/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:31:19.629347 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation input Value
Regional factor set US
Factor-return currency USD
Issuer-return basis USD adjusted total return
Estimation window 2025-08-19 to 2026-06-30
Aligned daily observations 217
Minimum observation requirement 120
Currency conversion for HK listings not required

Fama–French Three-Factor and Five-Factor Results

Diagnostic FF3 FF5
Annualised alpha -47.03% -33.06%
Adjusted R² 0.09 0.19
Annualised residual volatility 35.29% 33.19%
Factor loading (t-statistic) FF3 FF5
Market excess return (Mkt-RF) 0.62 (2.97) 1.15 (5.09)
Size (SMB) 0.76 (2.69) 0.58 (2.02)
Value (HML) 0.05 (0.21) -0.72 (-2.57)
Profitability (RMW) NM 0.65 (2.74)
Investment (CMA) NM 1.56 (3.77)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

us-equitystockequityefxindustrialsresearch--consulting-servicesnasdaq